FIELD: medicine.
SUBSTANCE: invention relates to use of a derivative of general formula I
,
where R1 and R2 independently of each other represent hydrogen, n is integer between 1 and 2, R3 is a -OH group or -O(C1-C6 alkyl), R4 is C1-C6 alkyl group, R5 and R6 independently represent a halogen atom or a pharmaceutically acceptable salt thereof as a therapeutic agent for treating and/or preventing muscular atrophy in mammals, and/or to limit muscular atrophy in mammals, and/or to stimulate muscle growth in training mammals seeking to increase muscle mass and quality, preventing symptoms of sarcopenia related to age or rehabilitation after loss of muscles, age-related muscular atrophy and/or consequences of drug treatment, and/or immobilisation, and/or cachexia.
EFFECT: disclosed are derivatives used for treating muscular atrophy.
12 cl, 1 dwg, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| USE OF TRYPTOPHAN METABOLITES FOR THE TREATMENT OF MUSCULAR ATROPHY | 2017 |
|
RU2806346C2 |
| CHEMICAL COMPOUNDS AND USE THEREOF TO IMPROVE QUALITY OF MUSCLES | 2015 |
|
RU2724329C2 |
| USE OF MYOSTATIN ANTAGONISTS, COMBINATION CONTAINING THEM AND THEIR USE | 2016 |
|
RU2781401C2 |
| COMPOUNDS MODULATING INTRACELLULAR CALCIUM | 2008 |
|
RU2465272C2 |
| TRIAZOLES FOR REGULATION OF INTRACELLULAR CALCIUM HOMEOSTASIS | 2017 |
|
RU2753509C2 |
| IMPROVED ANTIBODIES GDF-8 ANTAGONISTS AND THEIR USE | 2013 |
|
RU2630634C2 |
| NOVEL OXIME DERIVATIVES OF 3,5-SECO-4-NOR-CHOLESTANE, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME, AND METHOD FOR PRODUCTION THEREOF | 2009 |
|
RU2508289C2 |
| NEW OXIME CHOLEST-4-EN-3-ONE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND METHOD FOR PREPARING | 2009 |
|
RU2496784C2 |
| PHYTOECDYSONES AND DERIVATIVES THEREOF FOR USE IN TREATING NEUROMUSCULAR DISEASES | 2020 |
|
RU2820936C2 |
| THIOPHENE DERIVATIVES USED IN TREATMENT OF DIABETES | 2013 |
|
RU2663835C2 |
